Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors

Bioorganic & Medicinal Chemistry Letters
2018.0

Abstract

A series of novel pyrimidinedione derivatives were designed and evaluated for in vitro dipeptidyl peptidase-4 (DPP-4) inhibitory activity and in vivo anti-hyperglycemic efficacy. Among them, the representative compounds 11, 15 and 16 showed excellent inhibitory activity of DPP-4 with IC50 values of 64.47 nM, 188.7 nM and 65.36 nM, respectively. Further studies revealed that compound 11 was potent in vivo hypoglycemic effect. The structure-activity relationships of these pyrimidinedione derivatives had been discussed, which would be useful for developing novel DPP-4 inhibitors as treating type 2 diabetes.

Knowledge Graph

Similar Paper

Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Surrogating and redirection of pyrazolo[1,5- a ]pyrimidin-7(4 H )-one core, a novel class of potent and selective DPP-4 inhibitors
Bioorganic & Medicinal Chemistry 2018.0
Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554
Bioorganic & Medicinal Chemistry 2011.0
Identification of novel uracil derivatives incorporating benzoic acid moieties as highly potent Dipeptidyl Peptidase-IV inhibitors
Bioorganic & Medicinal Chemistry 2019.0
Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors
ACS Medicinal Chemistry Letters 2010.0
Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities
European Journal of Medicinal Chemistry 2020.0
New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study
European Journal of Medicinal Chemistry 2018.0
Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Molecular Design, Synthesis, and Hypoglycemic Activity of a Series of Thiazolidine-2,4-diones
Journal of Medicinal Chemistry 2000.0
Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes
Bioorganic & Medicinal Chemistry 2018.0